Reeve Emma

Reeve Emma is listed in filings as Director at PTC Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including sale activity. Recent filings connect the profile to PTC Therapeutics, Inc. (PTCT) and Whitehawk Therapeutics Inc (WHWK). The current snapshot covers public activity from Jun 16, 2025 to Jan 6, 2026. Reported amounts are shown as $55.8K to $266.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.